Walleye Trading LLC Purchases Shares of 13,357 CONMED Co. (NYSE:CNMD)

Walleye Trading LLC acquired a new stake in shares of CONMED Co. (NYSE:CNMD) in the third quarter, HoldingsChannel reports. The firm acquired 13,357 shares of the company’s stock, valued at approximately $961,000.

Other large investors have also recently made changes to their positions in the company. 1620 Investment Advisors Inc. purchased a new position in shares of CONMED in the 2nd quarter worth $39,000. Innealta Capital LLC purchased a new stake in CONMED during the second quarter valued at approximately $41,000. CWM LLC raised its position in CONMED by 224.7% during the second quarter. CWM LLC now owns 919 shares of the company’s stock valued at $64,000 after purchasing an additional 636 shares during the period. nVerses Capital LLC lifted its stake in shares of CONMED by 566.7% in the 3rd quarter. nVerses Capital LLC now owns 2,000 shares of the company’s stock valued at $144,000 after purchasing an additional 1,700 shares during the last quarter. Finally, Federated Hermes Inc. purchased a new position in shares of CONMED in the 2nd quarter worth approximately $167,000.

Analyst Ratings Changes

Several research analysts have commented on CNMD shares. Needham & Company LLC reaffirmed a “buy” rating and set a $97.00 price objective on shares of CONMED in a research note on Thursday, October 31st. StockNews.com downgraded shares of CONMED from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CONMED has an average rating of “Moderate Buy” and a consensus price target of $79.80.

CONMED Trading Down 1.4 %

Shares of CNMD opened at $74.92 on Wednesday. The company has a debt-to-equity ratio of 1.01, a current ratio of 2.27 and a quick ratio of 1.06. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of 17.80, a PEG ratio of 0.98 and a beta of 1.46. The company has a 50-day moving average of $69.45 and a 200 day moving average of $70.51. CONMED Co. has a 1-year low of $61.05 and a 1-year high of $117.27.

CONMED (NYSE:CNMD) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.06. The firm had revenue of $316.70 million during the quarter, compared to analyst estimates of $318.46 million. CONMED had a return on equity of 13.84% and a net margin of 10.23%. On average, research analysts expect that CONMED Co. will post 4.03 EPS for the current year.

CONMED Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.